Market Closed -
Japan Exchange
09:57:13 10/05/2024 am IST
|
5-day change
|
1st Jan Change
|
4,080
JPY
|
+2.13%
|
|
+1.75%
|
-2.86%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
30,900
|
63,100
|
46,350
|
50,599
|
41,999
|
40,799
|
-
|
-
|
Enterprise Value (EV)
1 |
28,451
|
57,420
|
42,669
|
55,865
|
57,388
|
40,799
|
40,799
|
40,799
|
P/E ratio
|
20.5
x
|
21.6
x
|
16.4
x
|
20.1
x
|
20.2
x
|
16.8
x
|
13.8
x
|
11.3
x
|
Yield
|
0.49%
|
0.93%
|
0.61%
|
0.5%
|
0.6%
|
0.74%
|
0.81%
|
0.93%
|
Capitalization / Revenue
|
1.07
x
|
1.69
x
|
1.12
x
|
1.18
x
|
0.92
x
|
0.82
x
|
0.73
x
|
0.64
x
|
EV / Revenue
|
1.07
x
|
1.69
x
|
1.12
x
|
1.18
x
|
0.92
x
|
0.82
x
|
0.73
x
|
0.64
x
|
EV / EBITDA
|
12.9
x
|
12.7
x
|
9.52
x
|
11.6
x
|
-
|
8.2
x
|
7.07
x
|
6.11
x
|
EV / FCF
|
2,38,24,208
x
|
1,85,81,909
x
|
-3,14,66,163
x
|
-58,56,422
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-0%
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
2.82
x
|
4.59
x
|
2.9
x
|
2.78
x
|
2.09
x
|
1.83
x
|
1.64
x
|
1.45
x
|
Nbr of stocks (in thousands)
|
10,000
|
10,000
|
10,000
|
10,000
|
10,000
|
10,000
|
-
|
-
|
Reference price
2 |
3,090
|
6,310
|
4,635
|
5,060
|
4,200
|
4,080
|
4,080
|
4,080
|
Announcement Date
|
13/02/20
|
12/02/21
|
10/02/22
|
14/02/23
|
13/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
28,763
|
37,393
|
41,205
|
42,891
|
45,628
|
50,000
|
56,000
|
64,000
|
EBITDA
1 |
2,389
|
4,975
|
4,868
|
4,368
|
-
|
4,973
|
5,773
|
6,673
|
EBIT
1 |
2,100
|
4,702
|
4,523
|
3,990
|
2,989
|
3,500
|
4,300
|
5,200
|
Operating Margin
|
7.3%
|
12.57%
|
10.98%
|
9.3%
|
6.55%
|
7%
|
7.68%
|
8.12%
|
Earnings before Tax (EBT)
1 |
2,149
|
4,450
|
4,285
|
3,851
|
3,184
|
3,600
|
4,400
|
5,300
|
Net income
1 |
1,505
|
2,920
|
2,820
|
2,521
|
2,082
|
2,430
|
2,950
|
3,600
|
Net margin
|
5.23%
|
7.81%
|
6.84%
|
5.88%
|
4.56%
|
4.86%
|
5.27%
|
5.62%
|
EPS
2 |
150.6
|
292.1
|
282.1
|
252.2
|
208.3
|
243.0
|
295.0
|
360.0
|
Free Cash Flow
|
1,297
|
3,396
|
-1,473
|
-8,640
|
-
|
-
|
-
|
-
|
FCF margin
|
4.51%
|
9.08%
|
-3.57%
|
-20.14%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
54.3%
|
68.26%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
86.18%
|
116.29%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
15.06
|
58.42
|
28.21
|
25.22
|
25.22
|
30.00
|
33.00
|
38.00
|
Announcement Date
|
13/02/20
|
12/02/21
|
10/02/22
|
14/02/23
|
13/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
---|
Net sales
1 |
14,990
|
16,974
|
20,419
|
20,414
|
10,186
|
10,605
|
20,791
|
10,417
|
10,546
|
20,963
|
10,505
|
11,423
|
21,928
|
10,999
|
11,198
|
22,197
|
11,451
|
11,660
|
11,940
|
23,600
|
12,830
|
13,570
|
26,400
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,108
|
1,785
|
2,917
|
2,546
|
1,007
|
970
|
1,977
|
1,294
|
1,031
|
2,325
|
849
|
816
|
1,665
|
786
|
982
|
1,768
|
780
|
380
|
620
|
1,000
|
1,630
|
910
|
2,540
|
Operating Margin
|
7.39%
|
10.52%
|
14.29%
|
12.47%
|
9.89%
|
9.15%
|
9.51%
|
12.42%
|
9.78%
|
11.09%
|
8.08%
|
7.14%
|
7.59%
|
7.15%
|
8.77%
|
7.97%
|
6.81%
|
3.26%
|
5.19%
|
4.24%
|
12.7%
|
6.71%
|
9.62%
|
Earnings before Tax (EBT)
1 |
1,129
|
1,733
|
2,717
|
2,358
|
1,002
|
925
|
1,927
|
1,312
|
1,006
|
2,318
|
882
|
651
|
1,533
|
814
|
1,079
|
1,893
|
799
|
390
|
630
|
1,020
|
1,650
|
930
|
2,580
|
Net income
1 |
788
|
1,136
|
1,784
|
1,550
|
659
|
611
|
1,270
|
869
|
659
|
1,528
|
570
|
423
|
993
|
521
|
705
|
1,226
|
513
|
250
|
430
|
680
|
1,000
|
750
|
1,750
|
Net margin
|
5.26%
|
6.69%
|
8.74%
|
7.59%
|
6.47%
|
5.76%
|
6.11%
|
8.34%
|
6.25%
|
7.29%
|
5.43%
|
3.7%
|
4.53%
|
4.74%
|
6.3%
|
5.52%
|
4.48%
|
2.14%
|
3.6%
|
2.88%
|
7.79%
|
5.53%
|
6.63%
|
EPS
|
-
|
113.6
|
-
|
155.0
|
65.90
|
-
|
-
|
86.91
|
-
|
152.8
|
56.95
|
-
|
-
|
52.10
|
-
|
122.6
|
51.32
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
13/02/20
|
11/08/20
|
12/02/21
|
10/08/21
|
09/11/21
|
10/02/22
|
10/02/22
|
10/05/22
|
09/08/22
|
09/08/22
|
08/11/22
|
14/02/23
|
14/02/23
|
09/05/23
|
08/08/23
|
08/08/23
|
13/11/23
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
5,266
|
15,389
|
-
|
-
|
-
|
Net Cash position
|
2,449
|
5,680
|
3,681
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
1.206
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
1,297
|
3,396
|
-1,473
|
-8,640
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
14.7%
|
23.7%
|
19%
|
14.7%
|
10.9%
|
11.4%
|
12.5%
|
13.5%
|
ROA (Net income/ Total Assets)
|
16.6%
|
29.1%
|
23.7%
|
15.5%
|
9.19%
|
9.6%
|
13.3%
|
15.1%
|
Assets
1 |
9,076
|
10,033
|
11,884
|
16,239
|
22,650
|
25,312
|
22,180
|
23,841
|
Book Value Per Share
2 |
1,094
|
1,375
|
1,598
|
1,822
|
2,006
|
2,224
|
2,489
|
2,816
|
Cash Flow per Share
|
179.0
|
319.0
|
317.0
|
290.0
|
303.0
|
-
|
-
|
-
|
Capex
1 |
105
|
459
|
2,831
|
8,914
|
8,852
|
2,000
|
1,000
|
1,000
|
Capex / Sales
|
0.37%
|
1.23%
|
6.87%
|
20.78%
|
19.4%
|
4%
|
1.79%
|
1.56%
|
Announcement Date
|
13/02/20
|
12/02/21
|
10/02/22
|
14/02/23
|
13/02/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -2.86% | 262M | | +9.48% | 27.43B | | -28.65% | 3.18B | | -16.08% | 2.53B | | +19.05% | 2.49B | | +11.11% | 2.16B | | -4.24% | 2.03B | | +1.69% | 1.31B | | +29.73% | 1.29B | | +8.01% | 1.17B |
Medical Supplies
|